A source-linked directory for specialist review—not a list of software certified or commercially licensed by Karam.
Mechanistic machine learning for prime-editing outcome prediction. The publisher labels the code and server as noncommercial-use only. Not bundled, rehosted or used by this website.
Version: consult original release; no Karam runtime validation.Author-lab pipeline and browser application for long-read amplicon editing outcomes. Match assay, version, license and interpretation scope before adoption. Not a whole-genome safety certificate.
Version: select and record before analysis; no Karam validation claim.Confirm the exact implementation, version, permissions, data handling and relevance to the analysis. A public repository is not an automatic commercial license. A published benchmark is not independent validation on the customer’s data. [C05] [C07] [C21]
Scientific summaries are adapted from the supplied 15 October 2026 CRISPR Project Assessment. Source records show the original references and review access; this release is not a new systematic review.
C05 — Hsu A, Chen PJ, Li AH, et al. Mechanistic machine learning for prediction of prime editing outcomes. Nature Biotechnology. 12 August 2026.C07 — Hwang GH, Vyshedskiy B, Barry T, et al. Analysing long-read CRISPR experiments with CRISPRLungo. Nature Biomedical Engineering. 20 August 2026.C21 — Broad Institute. Licensing gene editing systems. Current institutional policy reviewed 15 October 2026; administrative context.